The Rise Of The Non-Submission – A Worrying Trend For UK Patient Access With ‘Brexit’ Approaching

October 18, 2018 Danielle Twigg

The National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) make recommendations to inform public reimbursement of healthcare technologies based on their clinical- and cost-effectiveness in England and Scotland, respectively. Some companies choose not to make a submission resulting in a terminated appraisal and non-reimbursement. This research aims to systematically analyse all NICE and SMC terminated appraisals.

Authors: Richard Macaulay, Andrea Berardi, Ikhlaas Kasli

To find out more about this poster you can register to download it here after the ISPOR event.

Previous Article
Treatment Disruption Among Patients With Parkinson’s Disease With Psychosis Enrolled In US Centers For Medicare Services
Treatment Disruption Among Patients With Parkinson’s Disease With Psychosis Enrolled In US Centers For Medicare Services

Next Article
The Impact Of Landmark Response On Overall Survival: Implications For The Economic Evaluation Of Immune-Therapy (I-O) Treatment
The Impact Of Landmark Response On Overall Survival: Implications For The Economic Evaluation Of Immune-Therapy (I-O) Treatment